As a domestic PD-1 inhibitor, Toripalimab Injection is advantageous for its broad-spectrum anti-tumor effect, definite efficacy of monotherapy or combination chemotherapy against various advanced solid tumors.
Authentic
Guarantee
Fast Delivery
Privacy Toripalimab is a PD-1 inhibitor classified as an immune checkpoint inhibitor, mainly used for the treatment of various malignant tumors (e.g., melanom···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 75
Toripalimab (anti-PD-1 monoclonal antibody) is mainly indicated for the treatment of advanced solid tumors (such as melanoma, nasopharyngeal carcinoma···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 75
Toripalimab is a PD-1 inhibitor, a type of tumor immunotherapeutic drug, mainly used for the treatment of malignant tumors such as melanoma and nasoph···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 72
The recommended dose of toripalimab is usually 3 mg per kg of body weight, administered once every 2 weeks. The exact number of vials per dose is calc···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 76
Toripalimab is an anticancer drug classified as a PD-1 inhibitor. Its main ingredient is a monoclonal antibody targeting the PD-1 receptor on the surf···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 76
Toripalimab (a PD-1 inhibitor) should be used in special populations strictly following the principle of individualization. Key populations include ch···【Read More】
Update: 11 Feb,2026Source: Haiou HealthViews: 74
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



